Abstract: A method, apparatus and computer program product are provided to facilitate the efficient generation and submission of medical eligibility and medical claim data. In a method, a modified pharmacy benefits transaction associated with a patient is received that is formatted in a first predefined format. The modified pharmacy benefits transaction is parsed to determine an indicator and data is extracted from the modified pharmacy benefits transaction based on the indicator. A database is accessed to retrieve additional data that is at least partly based on a pharmacy with which the source is associated, a potential payor of the medical transaction or a medication that is a subject of the medical transaction. A medical transaction is generated that includes the extracted data and the additional data and formatted in a second predefined format. A response to the medical transaction is then transmitted to a source for display to a user.

Abstract: A childcare organizer having an interior cavity that can be selectively sectioned off by a shelving system that embodies a divider defined by a plurality of malleable slats is provided. The inner surfaces that define the interior cavity may have a first fastener, while the distal end of each divider slat has a corresponding second fastener, thereby connecting the ends of the slats to two or more inner surfaces defines one of almost innumerable permutations of where and how the slats are located and oriented, respectively, within the interior cavity. The interior cavity is accessible by way of a cover that is movable between an open condition and a closed condition. In the open condition, the cover acts as a ramp for a changing mat to unfurl down. The changing mat is storable in the interior cavity in a folded position.

Abstract: A method, apparatus and computer program product are provided to facilitate the efficient generation and submission of medical eligibility and medical claim data. In a method, a modified pharmacy benefits transaction associated with a patient is received that is formatted in a first predefined format. The modified pharmacy benefits transaction is parsed to determine an indicator and data is extracted from the modified pharmacy benefits transaction based on the indicator. A database is accessed to retrieve additional data that is at least partly based on a pharmacy with which the source is associated, a potential payor of the medical transaction or a medication that is a subject of the medical transaction. A medical transaction is generated that includes the extracted data and the additional data and formatted in a second predefined format. A response to the medical transaction is then transmitted to a source for display to a user.

Abstract: Various enhanced rocket fairings and associated mechanisms are discussed herein for split fairings with two fairing halves. In some implementations, electrically-actuated base clamps are included to deploy the rocket fairing by applying a spring force between a corresponding fairing half and a payload adapter, which directs movement of the fairing halves upwards and away from the payload adapter until release of the fairing halves. In other implementations, electrically-actuated fairing mechanisms are included to hold together a first fairing half and a second fairing half, and separate the first fairing half from the second fairing half using a spring force. In further implementations, one fairing half includes a tab feature configured to overlap a second fairing half. The tab feature can deform inward under a pressure differential between an exterior and a payload envelope to reduce a gap between the two fairing halves.

Abstract: Systems and methods are provided for generating an individual's longitudinal medication history. Consent to generate an individual's longitudinal medication history across a pharmacy(s) and a claims processor(s) is received. A first collection of medication history data corresponding to the individual is selectively identified from medication history data files associated with the claims processor(s) and a first plurality of individuals. The selective identification is based on a claims processor patient identifier(s) associated with the individual and the claims processor(s). A second collection of medication history data corresponding to the individual is selectively identified from medication history data files associated with the pharmacy(s) and a second plurality of individuals. The selective identification is based on a linking index(s) associated with the claims processor patient identifier(s).

Abstract: Stable, non-toxic, calcium phosphate nanoparticles are formed that incorporate one or more oligonucleotides. RNAi nucleotides may be incorporated and, in particular, siRNA nucleotides. Since the siRNA nanoparticles dissociate leaving only naturally occurring residual materials, calcium and phosphate, along with the siRNA, they are particularly useful as carrier vehicles. The ability to incorporate more than one siRNA provides a means to block or knock down the translation of multiple targeted proteins at the same time.

Abstract: A sanitary napkin and method of use. The sanitary napkin includes a length of material having a first end and a second end. A marking is disposed on a first end of the length of material. The length of material includes a plurality of perforations dividing the length of material into individual panels. The length of material is configured to maintain a folded configuration via folding of the individual panels along the perforations. A method of using the sanitary napkin includes folding the first end over the second, tearing the length of material along one of the perforations, folding an endmost panel over an adjacent panel, folding the first end over the second end, applying the panel having the marking thereon to the anus region in order to remove fecal matter therefrom, and folding the panel having the marking thereon downward toward the endmost panel.

Abstract: Stable, non-toxic, calcium phosphate nanoparticles are formed that incorporate one or more oligonucleotides. RNAi nucleotides may be incorporated and, in particular, siRNA nucleotides. Since the siRNA nanoparticles dissociate leaving only naturally occurring residual materials, calcium and phosphate, along with the siRNA, they are particularly useful as carrier vehicles. The ability to incorporate more than one siRNA provides a means to block or knock down the translation of multiple targeted proteins at the same time.

Abstract: An IV hanger providing a portable adjustable hanging attachment for conventional intravenous equipment comprises an attachment method, a pulley system, and a hanging bracket. The attachment method comprises a plurality of attachment means for attaching the apparatus to an elevated structure. The attachment method is integrally connected to a pulley system which allows a user to selectively adjust the height of the hanging bracket relative to the frame. The hanging bracket provides a plurality of attachment hooks for support of IV equipment. The apparatus is particularly adapted for veterinary field calls where ground-based support system are prone to damage or disturbance by animal patients.

Abstract: The present invention provides a method for the synthesis of unagglomerated, highly dispersed, stable core/shell nanocomposite particles comprised of preparing a reverse micelle microemulsion that contains nanocomposite particles, treating the microemulsion with a silane coupling agent, breaking the microemulsion to form a suspension of the nanocomposite particles by adding an acid/alcohol solution to the microemulsion that maintains the suspension of nanocomposite particles at a pH of between about 6 and 7, and simultaneously washing and dispersing the suspension of nanocomposite particles, preferably with a size exclusion HPLC system modified to ensure unagglomeration of the nanocomposite particles. The primary particle size of the nanocomposite particles can range in diameter from between about 1 to 100 nm, preferably from between about 10 to 50 nm, more preferably about 10 to 20 nm, and most preferably about 20 nm.

Abstract: The present invention provides a method of removing spectator ions and contaminants from aqueous suspensions of solid particles. In accordance with the method of the invention, the solid particles are transported across a phase boundary into a non-polar organic solvent, leaving the spectator ions and contaminants in the aqueous phase. To facilitate the efficient transportation of the solid particles across the phase boundary, the surface of the solid particles is coated with an amphiphilic polyelectrolyte. If desired, the solid particles can be recovered from the organic phase by evaporating the organic solvent.

Abstract: A hydrogen storage material includes a nano size material that can be formed in a multi-layered core/shell structure and/or in a nanotabular (or platelet) form.

Abstract: Solid, shaped and fired fibers of Ti4O7 and Ti5O9 are made by firing TiO2 fibers in a reducing atmosphere. In a first aspect, the TiO2 fibers are made by extruding into air a viscous TiO2 gel and heat treating the resulting green fibers to remove solvent, decompose and to volatilize undesired constituents to form electrically conductive, refractory fibers of Ti4O7 and Ti5O9. In a second aspect, solid, shaped and fired fibers of Ti4O7 and Ti5O9 are made by firing extruded fibers from mixtures of TiO2.

Abstract: A system and method for optimizing the systemic delivery of growth-arresting lipid-derived bioactive drugs or gene therapy agents to an animal or human in need of such agents utilizing nanoscale assembly systems, such as liposomes, resorbable and non-aggregating nanoparticle dispersions, metal or semiconductor nanoparticles, or polymeric materials such as dendrimers or hydrogels, each of which exhibit improved lipid solubility, cell permeability, an increased circulation half life and pharmacokinetic profile with improved tumor or vascular targeting.